pLentiRNACRISPR_005 - hU6-DR_BsmBI-EFS-RfxCas13d-NLS-2A-Puro-WPRE Citations (6)
Originally described in: Massively parallel Cas13 screens reveal principles for guide RNA design.Wessels HH, Mendez-Mancilla A, Guo X, Legut M, Daniloski Z, Sanjana NE Nat Biotechnol. 2020 Jun;38(6):722-727. doi: 10.1038/s41587-020-0456-9. Epub 2020 Mar 16. PubMed Journal
Articles Citing pLentiRNACRISPR_005 - hU6-DR_BsmBI-EFS-RfxCas13d-NLS-2A-Puro-WPRE
| Articles |
|---|
| Enhancer RNA Transcription Is Essential for a Novel CSF1 Enhancer in Triple-Negative Breast Cancer. Lewis MW, Wisniewska K, King CM, Li S, Coffey A, Kelly MR, Regner MJ, Franco HL. Cancers (Basel). 2022 Apr 6;14(7). pii: cancers14071852. doi: 10.3390/cancers14071852. PubMed |
Chemically-defined generation of human hemogenic endothelium and definitive hematopoietic progenitor cells.
Chang Y, Syahirah R, Oprescu SN, Wang X, Jung J, Cooper SH, Torregrosa-Allen S, Elzey BD, Hsu AY, Randolph LN, Sun Y, Kuang S, Broxmeyer HE, Deng Q, Lian X, Bao X.
Biomaterials. 2022 May 6;285:121569. doi: 10.1016/j.biomaterials.2022.121569.
PubMed
Associated Plasmids |
| Long noncoding RNA LINC00239 inhibits ferroptosis in colorectal cancer by binding to Keap1 to stabilize Nrf2. Han Y, Gao X, Wu N, Jin Y, Zhou H, Wang W, Liu H, Chu Y, Cao J, Jiang M, Yang S, Shi Y, Xie X, Chen F, Han Y, Qin W, Xu B, Liang J. Cell Death Dis. 2022 Aug 29;13(8):742. doi: 10.1038/s41419-022-05192-y. PubMed |
| Dissecting super-enhancer driven transcriptional dependencies reveals novel therapeutic strategies and targets for group 3 subtype medulloblastoma. Li M, Han Y, Wang C, Kang W, Jiang W, Zhang L, Tang Y. J Exp Clin Cancer Res. 2022 Oct 22;41(1):311. doi: 10.1186/s13046-022-02506-y. PubMed |
| Downregulation of hepatic lncRNA Gm19619 improves gluconeogenesis and lipogenesis following vertical sleeve gastrectomy in mice. Fang Z, Fan M, Yuan D, Jin L, Wang Y, Ding L, Xu S, Tu J, Zhang E, Wu X, Chen ZB, Huang W. Commun Biol. 2023 Jan 27;6(1):105. doi: 10.1038/s42003-023-04483-0. PubMed |
| Efficient CRISPR-Cas13d-Based Antiviral Strategy to Combat SARS-CoV-2. Hussein M, Andrade Dos Ramos Z, Vink MA, Kroon P, Yu Z, Enjuanes L, Zuniga S, Berkhout B, Herrera-Carrillo E. Viruses. 2023 Mar 6;15(3):686. doi: 10.3390/v15030686. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.